Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Ian Shott provides foreword to the ‘Engineering Biology: A Priority for Growth’ report

Our “Individuals, groups and communities working in engineering biology must get together at this important time and agree how they can build better connections and incentivise this collaboration to deliver more economic and societal impact.”

Our Executive Chairman, Ian Shott, discusses the potential for engineering biology to deliver economic and social benefits to the UK in the Royal Academy of Engineering’s ‘Engineering Biology: A Priority for Growth’ report. His foreword explores the need for urgent action to build upon the rapid progress in synthetic biology achieved in the last decade and accelerate commercialisation of emerging technologies. By supporting greater collaboration between different disciplines and industries, the UK can ensure that it is an international leader in engineering biology.

Read the report here

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.